Literature DB >> 7554583

Microbial surveillance of human islet isolation, in vitro culture, and cryopreservation.

J R Lakey1, R V Rajotte, G L Warnock.   

Abstract

The aim of these studies was to investigate microbiological contamination during the isolation and preservation of islets of Langerhans in a low-temperature tissue bank. Islets were isolated from the pancreases of 117 organ donors, then cryopreserved. In the initial 47, microbial culture was completed only after thawing: Enterobacter cloacae (n = 4) and gram-negative bacilli (n = 9) were isolated for a positive culture rate of 27.6%. It was not possible to ascertain the source of the contaminants, since cultures were taken only at the conclusion. A total of 70 consecutive pancreases were then subjected to islet isolation and cryopreservation while prospectively culturing at these steps: step 1, from the pancreas transport media; step 2, after intraductal perfusion of collagenase; step 3, after dissociation; step 4, after purification; step 5, following a 6-48-h in vitro culture; step 6, post-thaw; step 7, after dilution of the cryoprotective agent; and step 8, after final 48-h in vitro culture. The transport fluid was infected with aerobic gram-negative (n = 6), gram-positive (n = 5), and yeast microorganisms (n = 2) for an overall step 1 contamination rate of 19%. These contaminants were found in 9% of our local program vs. 26% from distantly procured pancreases. Contaminants at subsequent steps were 10% (step 2), 9% (step 3), so that only 3% were infected at the conclusion of isolation (step 4), and 0% after initial culture (step 5). Amongst pancreases that were initially sterile, new contaminants could be identified in 12% at step 2 and 8% at step 3; however, these also became undetectable.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7554583

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  5 in total

1.  Absence of the inferior mesenteric vein.

Authors:  C K Leow; D W Gray
Journal:  Ann Surg       Date:  1997-04       Impact factor: 12.969

2.  Microbial contamination of clinical islet transplant preparations is associated with very low risk of infection.

Authors:  Boris Gala-Lopez; Tatsuya Kin; Doug O'Gorman; Andrew R Pepper; Peter Senior; Atul Humar; A M James Shapiro
Journal:  Diabetes Technol Ther       Date:  2013-02-25       Impact factor: 6.118

3.  Early Infectious Complications After Total Pancreatectomy with Islet Autotransplantation: a Single Center Experience.

Authors:  Justyna E Gołębiewska; Piotr J Bachul; Natalie Fillman; Mark R Kijek; Lindsay Basto; Monica Para; Laurencia Perea; Karolina Gołąb; Ling-Jia Wang; Martin Tibudan; Alicja Dębska-Ślizień; Jeffrey B Matthews; John Fung; Piotr Witkowski
Journal:  J Gastrointest Surg       Date:  2019-02-04       Impact factor: 3.452

4.  Infectious complications of pancreatic islet transplantation: clinical experience and unanswered questions.

Authors:  Stephanie M Pouch
Journal:  Curr Infect Dis Rep       Date:  2015-05       Impact factor: 3.725

5.  Prophylactically Decontaminating Human Islet Product for Safe Clinical Application: Effective and Potent Method.

Authors:  Meirigeng Qi; Keiko Omori; Yoko Mullen; Brian McFadden; Luis Valiente; Jemily Juan; Shiela Bilbao; Bernard R Tegtmeier; Donald Dafoe; Fouad Kandeel; Ismail H Al-Abdullah
Journal:  Transplant Direct       Date:  2016-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.